hero-654791312-sized

Ensights

Science that is transforming lives and enabling the future

Is your Single-Use Solution Ready for Cell and Gene Therapy and Synthetic Gene Production?

All Posts

Is your Single-Use Solution Ready for Cell and Gene Therapy and Synthetic Gene Production?

The growth of the biomanufacturing industry has created a demand for new and high-performance fluid handling systems and technologies for the management and storage of cell and gene therapy intermediates and gene-based medicines. New modalities come with risks that don’t yet have good solutions.

One of the biggest risks is contamination. Samples of synthetic DNA can be contaminated with DNA or RNA fragments or worse yet, RNase and DNase from the lab, the environment, the operator, or from single-use components. Even tiny amounts of contamination can be a problem, as they can enter a PCR reaction or enzymatic reagents and amplify during the reaction. This can lead to misleading results, false positives, and even the development of ineffective drugs. Another risk is that synthetic DNA can degrade over time. This can be caused by several factors, including exposure to heat, light, and moisture. Degradation can reduce the effectiveness of synthetic DNA and make it less likely to achieve its intended therapeutic effect.

This is best demonstrated in a recent study and webinar utilizing our Aramus™ Bag versus a traditional polyethylene bag. Aramus™ extremely robust material with lower particle profile vs polyethylene, with a low extractable and leachable profile delivered a human DNA free, DNase free, and RNase free profile in comparison to its (multilayered) polyethylene counterpart-which left traces of contamination. We used sensitive molecular markers and detection assays to monitor contamination level to ensure Aramus is the optimized container in synthetic biology applications and cell and gene therapy workflows. Not only have these bags been validated for use in the storage of synthetic DNA, but their toughness is shown to be effective at preventing contamination and degradation, even under extreme conditions.

It’s important to note that not all solutions are equal, in fact traditional bags constructed of materials such as EVA, FEP, and ULDPE performed worse than Aramus™ bags in benchmark studies in terms of subvisible particulate profiles and aptasensing capability, drastically increasing risk of exposing patients to potential contaminants, and leaving scientists on the hunt to track down what went wrong during stability or other clinical studies. With such time sensitive material coupled with high patient levels, do you have time to balance an exposure or contamination? Even if you have time, would you want to?

While the industry is still on the precipice of synthetic and clinical DNA technology development, the need for safeguards throughout the nucleic acid manufacturing process is critical. Having the best container solution can eliminate myriad contaminants and poor performance and ensure gene drugs safety from early candidates’ discovery and development to late clinical stages. For long-term and low-temperature storage of small amounts of RNA/DNA, it is important to identify a robust and clean polymer surface with ultra-low non-specific adsorption.

Do you know what’s in your bag? Learn more about how to protect your DNA.

Related Posts

Exploring the Superiority of Silicon Carbide in Optical Components

Exploring the Superiority of Silicon Carbide in Optical Components Silicon carbide (SiC) is a leading material for high-performance optical components, offering numerous advantages over traditional materials such as glass and metal. Its exceptional specific stiffness, high thermal conductivity, and outstanding dimensional stability position SiC as a superior choice compared to beryllium and low-expansion glass ceramics. Historically, the high costs associated with the preliminary shaping and final finishing of SiC have hindered its widespread adoption in optical systems. The material is both hard and strong, requiring precision machining with expensive diamond tooling on high-quality, rigid machine tools. However, advances in manufacturing techniques, such as near-net-shape slip casting, have demonstrated success in reducing costs despite necessitating significant diamond grinding. Building on this success, Entegris offers an entirely new way of creating SiC. Using our chemical vapor conversion process, we can create net- or near net-shaped SiC components in complex forms while spending much less time on fabrication.

Designing for Extended Performance in Life Science Contaminant Removal

Designing for Extended Performance in Life Science Contaminant Removal Filters have a finite lifetime, and their performance also changes over time. How do you get the most performance over the longest lifespan?

Entegris Offers New FOUP Form-Factors for Non-Standard Wafers

Entegris Offers New FOUP Form-Factors for Non-Standard Wafers Over the last few years, 3D stacking has gone from a relatively niche fabrication method to an absolute necessity for cutting-edge applications. As chipmakers delve into smaller and smaller nodes, stacking and die-bonding wafers has become a preferred way of creating more processing power in a smaller space. Stacked and bonded wafers don’t behave the same way as 2D wafers: Wafers are thinned prior to bonding, which results in wafers that can sag when handled Bonded wafers are thicker and heavier than 2D wafers when assembled Bonded wafers can also warp following assembly Many automation tools rely on the predictable geometry and characteristics of 2D silicon wafers for safe handling and transport. While stacked and bonded wafers are a game-changer for miniaturization, they can also force manufacturing compromises unless chipmakers adopt specialized tools for the back end of the line (BEOL).